The Best Of BioTech IQ - Podgo

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

Site

RSS

Apple

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://pcm.adswizz.com
48 partages
https://wefunder.com/brazenbio/
2 partages
https://www.qualigeninc.com/
2 partages

https://www.linkedin.com/company/brazenbio/
2 partages
https://www.linkedin.com/in/shawnsingh/
1 partage
https://www.linkedin.com/in/brian-culley-7b219a1/
1 partage

https://www.amazon.com/Why-Resist-Surprising-Healthcare-Communicators/dp/057854766X
1 partage

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

A Journey From Investment Banker To The CEO Of A Biotech Developing Cancer Therapy With Bryan Kobel

Épisode 65

mercredi 24 septembre 2025 • Durée 50:10

Bryan Kobel decided to pursue a career in biotech after seeing its massive opportunities to change the world. He sits down with Ammon Rivera to share how he translated his background as an investment banker into his role as the CEO of TC BioPharm, a company that develops cancer therapy. He opens up about finding his purpose in this space that allows him to save lives and molds him into a compassionate leader. Bryan also talks about their allogenic Gamma Delta T Cell therapy platform, which involves injecting isolated Gamma Delta T Cells to treat cancer-stricken patients. He explains how they are continuously evolving this method to make it cost-effective and easily accessible to underserved and economically disadvantaged individuals.